Bacterial type I signal peptidase inhibitors - Optimized hits from nature
Natalia Szałaj(Jagiellonian University), Anna Więckowska(Jagiellonian University), Anders Karlén(Uppsala University), Sherry L. Mowbray(Uppsala University), Andrea Benediktsdottir(Uppsala University), Dominika Rusin(University of Southern Denmark)
Cited by 18
Related Papers
The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public–private partnerships for the development of new strategies to tackle antibiotic resistance
|Journal of Antimicrobial Chemotherapy|2015|129
Structures of Mycobacterium tuberculosis 1-Deoxy-D-xylulose-5-phosphate Reductoisomerase Provide New Insights into Catalysis
|Journal of Biological Chemistry|2007|87
Synergistic Targeting of Innate Receptors TLR7 and NOD2 for Therapeutic Intervention in Multiple Sclerosis
|International Journal of Molecular Sciences|2024|5
Neonatal Microglia and Their Secretome as Mediators of Brain Repair
|bioRxiv (Cold Spring Harbor Laboratory)|2025|1